CD40 expression correlates with response to immunotherapy in melanoma patients Vanderbilt Medical School - Basic Sciences, 01 Mar 2022 L-R: Ann Richmond, Chi…
Preclinical study shows promise of rigosertib as booster drug with immunotherapy treatment for melanoma VUMC News, 01 Jul 2021 by Tom…